Quality Safety Comparative Effectiveness Research Training (QSCERT)

质量安全比较有效性研究培训(QSCERT)

基本信息

  • 批准号:
    8544737
  • 负责人:
  • 金额:
    $ 21.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2018-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Comparative effectiveness research and patient-centered outcomes research are widely agreed to be a key strategy for improving the physical and economic health of the nation. Research on quality, safety and comparative effectiveness will provide the knowledge urgently needed to improve health outcomes and lower costs. A particular shortage of trained researchers in the areas of surgical, trauma, and urgent/emergency care quality, safety and comparative effectiveness research is made more pressing by the high impacts and costs of surgical and trauma care. None of the existing AHRQ-supported T32 programs specifically focus in these clinical domains. Therefore, the overall goal of the proposed UC Davis Quality, Safety, And Comparative Effectiveness Research Training (QSCERT) T32 program, led by Joy Melnikow, MD, MPH, is to establish a multidisciplinary, postdoctoral training program in quality, safety, and comparative effectiveness research with a particular emphasis on training researchers from all relevant disciplines in surgical, trauma, and urgent/ emergency care quality and outcomes. Given UC Davis' extensive research training and academic infrastructure, QSCERT has the capacity to nurture such a cadre of researchers. QSCERT will admit three postdoctoral fellows (MD or PhD) per year to participate in a two-year training program (in special circumstances, scholars may be recruited for one year). The QSCERT curriculum includes the core requirements of didactic training, career development training, and mentored research experience, with the option to earn a Master in Public Health (MPH) or Master in Advanced Study (MAS) degree. For didactic training, an effective array of courses and career development workshops have been chosen from established training programs to form the core QSCERT curriculum, providing scholars with the core competencies and in depth knowledge required for successful careers in quality, safety and comparative effectiveness research. For mentored training, scholars will be matched to a primary faculty mentor and a multidisciplinary mentorship team drawn from institutional Centers (the Center for Healthcare Policy and Research, Cancer Center, Center for Poverty Research, and the Institute of Population Health Improvement), the Departments of Medicine, Surgery, Emergency Medicine, and Public Health Sciences, and the Betty Irene School of Nursing. As home to one of the National Center for Research Resources' (NCRR) vanguard Clinical and Translational Science Centers, UC Davis has a strong track record in developing and maintaining interdisciplinary research programs. Through the Center for Healthcare Policy and Research, UC Davis has also built a prominent multidisciplinary research program in quality, safety, and CER, with a successful primary care faculty development program supported by the Health Resources and Services Administration (HRSA). We will leverage our experience and established infrastructure to create an interdisciplinary training program that will build our national capacity for research focused on improving health care outcomes for the American people.
比较有效性研究和以患者为中心的结果研究被广泛认为是改善国家身体和经济健康的关键战略。关于质量、安全性和相对有效性的研究将提供改善健康结果和降低成本所急需的知识。在外科、创伤和紧急/急救护理质量、安全性和比较有效性研究领域,训练有素的研究人员特别短缺,这一点由于外科和创伤护理的高影响和高成本而变得更加紧迫。现有的AHRQ支持的T32计划都没有专门关注这些临床领域。因此,拟议的加州大学戴维斯分校质量,安全性和比较有效性研究培训(QSCERT)T32计划的总体目标,由Joy Melnikow,MD,MPH领导,是建立一个多学科的博士后培训计划,质量,安全性和比较有效性研究,特别强调培训来自外科,创伤,紧急/紧急护理质量和结果。鉴于加州大学戴维斯分校广泛的研究培训和学术基础设施,QSCERT有能力培养这样一批研究人员。QSCERT每年将招收3名博士后(MD或PhD)参加为期两年的培训计划(特殊情况下,学者可以招募一年)。QSCERT课程包括教学培训,职业发展培训和指导研究经验的核心要求,可选择获得公共卫生硕士(MPH)或高级研究硕士(MAS)学位。对于教学培训,从已建立的培训计划中选择了一系列有效的课程和职业发展研讨会,以形成核心QSCERT课程,为学者提供质量,安全和比较有效性研究方面成功职业所需的核心能力和深入知识。对于指导培训,学者将匹配到一个初级教师导师和一个多学科的导师团队从机构中心(中心医疗保健政策和研究,癌症中心,中心贫困研究,人口健康改善研究所),医学,外科,急诊医学和公共卫生科学的部门,和护理的贝蒂艾琳学校。作为国家研究资源中心(NCRR)先锋临床和转化科学中心之一的所在地,加州大学戴维斯分校在开发和维护跨学科研究项目方面有着良好的记录。通过医疗保健政策和研究中心,加州大学戴维斯分校还建立了一个突出的质量,安全和CER多学科研究计划,并在卫生资源和服务管理局(HRSA)的支持下成功开展了初级保健教师发展计划。我们将利用我们的经验和已建立的基础设施,创建一个跨学科的培训计划,这将建立我们的国家研究能力,重点是改善美国人民的医疗保健成果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOY MELNIKOW其他文献

JOY MELNIKOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOY MELNIKOW', 18)}}的其他基金

Quality Safety Comparative Effectiveness Research Training (QSCERT)
质量安全比较有效性研究培训(QSCERT)
  • 批准号:
    8880125
  • 财政年份:
    2013
  • 资助金额:
    $ 21.96万
  • 项目类别:
Quality Safety Comparative Effectiveness Research Training (QSCERT)
质量安全比较有效性研究培训(QSCERT)
  • 批准号:
    8690892
  • 财政年份:
    2013
  • 资助金额:
    $ 21.96万
  • 项目类别:
Quality Safety Comparative Effectiveness Research Training (QSCERT)
质量安全比较有效性研究培训(QSCERT)
  • 批准号:
    9301466
  • 财政年份:
    2013
  • 资助金额:
    $ 21.96万
  • 项目类别:
CD11-1102, Promoting Health Policy and Disease Prevention
CD11-1102,促进卫生政策和疾病预防
  • 批准号:
    8313099
  • 财政年份:
    2011
  • 资助金额:
    $ 21.96万
  • 项目类别:
Surveillance Strategies Following Treatment for CIN
CIN 治疗后的监测策略
  • 批准号:
    7072152
  • 财政年份:
    2005
  • 资助金额:
    $ 21.96万
  • 项目类别:
Surveillance Strategies Following Treatment for CIN
CIN 治疗后的监测策略
  • 批准号:
    7237193
  • 财政年份:
    2005
  • 资助金额:
    $ 21.96万
  • 项目类别:
Surveillance Strategies Following Treatment for CIN
CIN 治疗后的监测策略
  • 批准号:
    6927716
  • 财政年份:
    2005
  • 资助金额:
    $ 21.96万
  • 项目类别:
TAMOXIFEN & BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS
他莫昔芬
  • 批准号:
    6648077
  • 财政年份:
    2000
  • 资助金额:
    $ 21.96万
  • 项目类别:
TAMOXIFEN & BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS
他莫昔芬
  • 批准号:
    6494994
  • 财政年份:
    2000
  • 资助金额:
    $ 21.96万
  • 项目类别:
TAMOXIFEN & BREAST CANCER--ACCEPTANCE/COST EFFECTIVENESS
他莫昔芬
  • 批准号:
    6377845
  • 财政年份:
    2000
  • 资助金额:
    $ 21.96万
  • 项目类别:

相似海外基金

Comparative Safety and Efficacy of Low-dose Vitamin D in Kidney Failure
小剂量维生素 D 治疗肾衰竭的安全性和疗效比较
  • 批准号:
    10721791
  • 财政年份:
    2023
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Effectiveness and Safety of Adjuvanted and Other Influenza Vaccine Technologies Among Patients Receiving Dialysis
佐剂和其他流感疫苗技术在接受透析的患者中的有效性和安全性比较
  • 批准号:
    10726047
  • 财政年份:
    2023
  • 资助金额:
    $ 21.96万
  • 项目类别:
The Comparative Effectiveness and Safety of Oral Anticoagulants in Patients with Cirrhosis and Atrial Fibrillation
口服抗凝药对肝硬化合并心房颤动患者的有效性和安全性比较
  • 批准号:
    10559071
  • 财政年份:
    2023
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies
骨质疏松症药物治疗的有效性和安全性比较
  • 批准号:
    10700169
  • 财政年份:
    2022
  • 资助金额:
    $ 21.96万
  • 项目类别:
Causal Inference for Better Understanding Clinical Trials Results: Reconciling Discrepant Comparative Evidence from Two Major Cardiovascular Safety Trials of Urate-Lowering Therapy
更好地理解临床试验结果的因果推断:调和两个主要降尿酸治疗心血管安全性试验的差异比较证据
  • 批准号:
    10507247
  • 财政年份:
    2022
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Safety of Antibiotics for Common Bacterial Infections During Pregnancy
妊娠期常见细菌感染抗生素的比较安全性
  • 批准号:
    10391036
  • 财政年份:
    2022
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies
骨质疏松症药物治疗的有效性和安全性比较
  • 批准号:
    10514723
  • 财政年份:
    2022
  • 资助金额:
    $ 21.96万
  • 项目类别:
Causal Inference for Better Understanding Clinical Trials Results: Reconciling Discrepant Comparative Evidence from Two Major Cardiovascular Safety Trials of Urate-Lowering Therapy
更好地理解临床试验结果的因果推断:调和两个主要降尿酸治疗心血管安全性试验的差异比较证据
  • 批准号:
    10662563
  • 财政年份:
    2022
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Safety of Seizure Prophylaxis within the Medicare Program
医疗保险计划中癫痫预防的比较安全性
  • 批准号:
    10277748
  • 财政年份:
    2021
  • 资助金额:
    $ 21.96万
  • 项目类别:
Comparative Safety of Seizure Prophylaxis within the Medicare Program
医疗保险计划中癫痫预防的比较安全性
  • 批准号:
    10495203
  • 财政年份:
    2021
  • 资助金额:
    $ 21.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了